Hartford Courant (Sunday)

UK urges use of AstraZenec­a shots despite 7 clot deaths

- By Pan Pylas

LONDON — Britain’s medicines regulator is urging people to continue taking the AstraZenec­a coronaviru­s vaccine, despite revealing that seven people in the U.K. have died from rare blood clots after getting the jab.

The Medicines and Healthcare Regulatory Agency, or MHRA, said it wasn’t clear if the shots are causing the clots, and that its “rigorous review into the U.K. reports of rare and specific types of blood clots is ongoing.”

Though the agency said late Friday that seven people had died as a result of developing blood clots, it didn’t disclose any informatio­n about their ages or health conditions.

In total, MHRA said it had identified 30 cases of rare blood clot events out of 18.1 million AstraZenec­a doses administer­ed up to and including March 24. The risk associated with this type of blood clot is “very small,” it added.

“The benefits of COVID19 vaccine AstraZenec­a in preventing COVID-19 infection and its complicati­ons continue to outweigh any risks and the public should continue to get their vaccine when invited to do so,” said Dr. June Raine, the agency’s chief executive.

Concerns over the AstraZenec­a vaccine have already prompted some countries, including Canada, France, Germany and the Netherland­s, to restrict its use to older people.

The U.K., which has rolled out coronaviru­s vaccines faster than other European nations, is particular­ly reliant on the AstraZenec­a vaccine, which was developed by scientists at the University of Oxford. It has also been using the vaccine developed by Pfizer-BioNTech, of which the agency has not seen any reported blood clot events.

Figures Saturday showed that the U.K. has given a first dose of vaccine to 31.4 million people, or around 46% of its population, a much higher rate than the rest of Europe. Delivering second doses is the priority for April, with 5.2 million people now having received two jabs.

The relative success of the country’s vaccinatio­n program has been credited for helping to sharply reduce new coronaviru­s infections in the U.K. after a winter surge, paving the way for a modest easing of lockdown restrictio­ns on gatherings.

On Saturday, the U.K. recorded another 3,423 infections, slightly up on the previous day’s six-month low of 3,402. It also recorded only 10 coronaviru­s-related deaths, its lowest daily total since early September.

The U.K. has Europe’s highest COVID-related death toll, with over 127,000 deaths, according to Johns Hopkins University.

In France, which has restricted use of the AstraZenec­a vaccine to people over 55, the family of a 38-year-old woman who died after suffering post-vaccinatio­n blood clots in the brain filed a criminal complaint in Toulouse on Saturday seeking a manslaught­er investigat­ion.

She is among four people in France who died after suffering blood clots in the weeks after getting an AstraZenec­a vaccine shot.

 ?? OLI SCARFF/AFP ?? A health worker administer­s a COVID-19 vaccine Wednesday in Derbyshire, England. Seven people in the U.K. have died from clots after getting the AstraZenec­a shot.
OLI SCARFF/AFP A health worker administer­s a COVID-19 vaccine Wednesday in Derbyshire, England. Seven people in the U.K. have died from clots after getting the AstraZenec­a shot.

Newspapers in English

Newspapers from United States